share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Taraporevala Cyrus

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Taraporevala Cyrus

輝瑞 | 4：持股變動聲明-董事 Taraporevala Cyrus
美股sec公告 ·  07/02 07:29
牛牛AI助理已提取核心訊息
Cyrus Taraporevala, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock on June 27, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, have not been disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding Pfizer stock.
Cyrus Taraporevala, a reporting person for Pfizer Inc [PFE], has engaged in a transaction involving the company's stock on June 27, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, have not been disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding Pfizer stock.
輝瑞公司[PFE]的報告人Cyrus Taraporevala於2024年6月27日參與了一項涉及該公司股票的交易。此次交易的具體細節，包括行動類型、狀態幣、涉及的股票數量、股份性質、成交價格和交易後的參股金融，均未在公告中披露。建議投資者等待更多信息，以充分了解此事件對他們的投資決策在輝瑞股票方面的影響。
輝瑞公司[PFE]的報告人Cyrus Taraporevala於2024年6月27日參與了一項涉及該公司股票的交易。此次交易的具體細節，包括行動類型、狀態幣、涉及的股票數量、股份性質、成交價格和交易後的參股金融，均未在公告中披露。建議投資者等待更多信息，以充分了解此事件對他們的投資決策在輝瑞股票方面的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。